GAD1 and COVID-19: At Time 2, according to the scales’ cut-offs, we found reduction rates ranging from 8% for GAD to 25% for GHQ; IES-R showed the smallest proportion of scores above the cut-off compared to GHQ-12 and GAD-7, suggesting a general remission for post-traumatic symptoms related to the COVID-19 pandemic.